Fifth Third Bancorp’s Oncolytics Biotech ONCY Stock Holding History

Fifth Third Bancorp’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$1K	–	2718
2022 Q2	$1K	Sell	1,000 -10,000	-91%	-$12.2K	﹤0.01%	2558
2022 Q1	$17K	Buy	11,000 +10,000	+1,000%	+$16.8K	﹤0.01%	1879
2021 Q4	$1K	Hold	1,000	–	–	﹤0.01%	2627
2021 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2482
2021 Q2	$3K	Hold	1,000	–	–	﹤0.01%	2300
2021 Q1	$4K	Hold	1,000	–	–	﹤0.01%	2228
2020 Q4	$2K	Hold	1,000	–	–	﹤0.01%	2236
2020 Q3	$2K	Hold	1,000	–	–	﹤0.01%	2064
2020 Q2	$2K	Hold	1,000	–	–	﹤0.01%	1981
2020 Q1	$1K	Buy	+1,000	New	+$2.5K	﹤0.01%	2058

Other funds holding ONCY

IAIM

International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $61.3B AUM 39.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BAM

Brave Asset Management Summit, New Jersey $467M AUM 33.05% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Fifth Third Bancorp's ONCY Position: Q3 2022 in Review

Fifth Third Bancorp sold out of Oncolytics Biotech (ONCY) in Q3 2022, closing a stake of 1,000 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in ONCY in Q1 2020 and held it in 10 quarters. The position peaked at $17K in Q1 2022. 36 funds tracked by Wall St. Rank hold ONCY as of Q3 2022.

Fifth Third Bancorp reported no remaining Oncolytics Biotech position as of Q3 2022 after selling out during the quarter.
Fifth Third Bancorp sold 1,000 Oncolytics Biotech shares in Q3 2022, an estimated $1K.
Fifth Third Bancorp first reported a position in Oncolytics Biotech in Q1 2020 and held it in 10 quarters.
Fifth Third Bancorp's Oncolytics Biotech position peaked at $17K in Q1 2022.
36 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q3 2022.

Based on Fifth Third Bancorp's 13F filing for Q3 2022, filed 25 Oct 2022.